Skip to main content
Top
Published in: Neurological Sciences 6/2013

01-06-2013 | Original Article

Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years

Authors: X. Huang, W. B. Liu, L. N. Men, H. Y. Feng, Y. Li, C. M. Luo, L. Qiu

Published in: Neurological Sciences | Issue 6/2013

Login to get access

Abstract

The objectives of the study are to study the clinical features of myasthenia gravis in southern China. A retrospective study was carried out on all patients who were diagnosed with myasthenia gravis at the First Affiliated Hospital of Sun Yat-sen University during 1987–2009. Of the 2,154 myasthenia gravis patients, the gender ratio (male:female) was 1:1.15. The median age at onset was 18 years. There was a single peak distribution of age at onset, and 44.8  % were children (≤14 years) at first onset. 1,766 patients (82.0 %) only had ocular symptoms at onset. 1,451 patients (67.4 %) were classified as Osserman grade I. 250 unselected patients received anti-acetylcholine receptor antibodies test, in which only 51.2 % were positive. Computed tomography scan/magnetic resonance Imaging of chest were done in 1,354 patients, of which 899 patients (66.4 %) had thymic hyperplasia and 201(14.8 %) had thymoma. There were 150 patients (7.0 %) with myasthenia gravis combined with other autoimmune diseases, in which hyperthyroidism was most common (84 %). 189 (8.8 %) patients experienced 267 episodes of crisis. The rate of family myasthenia gravis was 1.6 % (35/2,154). In conclusion, the clinical features and demography of myasthenia gravis patients in this study are significantly different from prior studies on other regions and ethnic groups.
Literature
1.
go back to reference Jaretzki A III, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70 327–324 Jaretzki A III, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70 327–324
2.
go back to reference Victor M, Ropper AH (2001) Myasthenia gravis and related disorders of the neuromuscular junction. In: Victor M, Ropper AH (eds) Adams and Victor’s principles of neurology, 7th edn. McGraw-Hill, New York, pp 1536–1539 Victor M, Ropper AH (2001) Myasthenia gravis and related disorders of the neuromuscular junction. In: Victor M, Ropper AH (eds) Adams and Victor’s principles of neurology, 7th edn. McGraw-Hill, New York, pp 1536–1539
3.
go back to reference Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Hojer-Pedersen KE, Rasmussen K et al (1998) Mortality and survival in myasthenia gravis: a Danish population based study. Neurol Neurosurg Psychiatry 64:78–83CrossRef Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Hojer-Pedersen KE, Rasmussen K et al (1998) Mortality and survival in myasthenia gravis: a Danish population based study. Neurol Neurosurg Psychiatry 64:78–83CrossRef
4.
go back to reference Cui LY, Tang XF, Xu XH (1994) Clinical type, electromyography and AchRab in MG patients. Clin J Neurol 1:65–67 Cui LY, Tang XF, Xu XH (1994) Clinical type, electromyography and AchRab in MG patients. Clin J Neurol 1:65–67
5.
go back to reference Stalberg E, Trontelj J (1979) Single fiber electromyography. Mirvalle Press, New York, pp 103–122 Stalberg E, Trontelj J (1979) Single fiber electromyography. Mirvalle Press, New York, pp 103–122
6.
go back to reference Kirmani JF, Yahia AM, Qureshi AI (2004) Myasthenic crisis. Curr Treat Options Neurol 6:13–15CrossRef Kirmani JF, Yahia AM, Qureshi AI (2004) Myasthenic crisis. Curr Treat Options Neurol 6:13–15CrossRef
7.
go back to reference Xu J, Yang M, Li Baohua et a1 (1999) Myasthenia gravis: clinical study in 2385 patients. Chin J Neurol 32(6):347–350 Xu J, Yang M, Li Baohua et a1 (1999) Myasthenia gravis: clinical study in 2385 patients. Chin J Neurol 32(6):347–350
8.
go back to reference Kawaguchi N, Kuwabara S, Nemoto Y et al (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000. Neurol Sci 224:43–47CrossRef Kawaguchi N, Kuwabara S, Nemoto Y et al (2004) Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999–2000. Neurol Sci 224:43–47CrossRef
9.
go back to reference Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. Neurol Neurosurg Psychiatry 71:352–356CrossRef Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. Neurol Neurosurg Psychiatry 71:352–356CrossRef
10.
go back to reference Robertson NP, Deans J, Compston DA (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. Neurol Neurosurg Psychiatry 65:492–496CrossRef Robertson NP, Deans J, Compston DA (1998) Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. Neurol Neurosurg Psychiatry 65:492–496CrossRef
11.
go back to reference Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurology India 56(3):352–355 Singhal BS, Bhatia NS, Umesh T, Menon S (2008) Myasthenia gravis: a study from India. Neurology India 56(3):352–355
12.
go back to reference Thanvi BR, Lo TC (2004) Update on myasthenia gravis. Postgrad Med 80:690–700CrossRef Thanvi BR, Lo TC (2004) Update on myasthenia gravis. Postgrad Med 80:690–700CrossRef
13.
go back to reference Lok Wing, Das Asha, Helen TL (2003) Myasthenia gravis in Singapore. Neuro J Southeast Asia 8:35–40 Lok Wing, Das Asha, Helen TL (2003) Myasthenia gravis in Singapore. Neuro J Southeast Asia 8:35–40
14.
go back to reference Yu YL, Hawkins BR, Ip MS, Wong V, Woo E (1992) Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 86:113–119PubMedCrossRef Yu YL, Hawkins BR, Ip MS, Wong V, Woo E (1992) Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 86:113–119PubMedCrossRef
15.
go back to reference Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R et al (1998) Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 14:381–387PubMedCrossRef Guidetti D, Sabadini R, Bondavalli M, Cavalletti S, Lodesani M, Mantegazza R et al (1998) Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy. Eur J Epidemiol 14:381–387PubMedCrossRef
16.
go back to reference Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. Neurol Neurosurg Psychiatry 78:1109–1112CrossRef Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. Neurol Neurosurg Psychiatry 78:1109–1112CrossRef
17.
go back to reference Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP (2004) Thymoma: a pathological study of 50 cases. Postgrad Med 50:94–99 Vaideeswar P, Padmanabhan A, Deshpande JR, Pandit SP (2004) Thymoma: a pathological study of 50 cases. Postgrad Med 50:94–99
18.
go back to reference Roy A, Kalita J, Misra UK, Kar D, Agarwal A, Misra SK (2000) A study of myasthenia gravis in patients with and without thymoma. Neurol India 48:343–346PubMed Roy A, Kalita J, Misra UK, Kar D, Agarwal A, Misra SK (2000) A study of myasthenia gravis in patients with and without thymoma. Neurol India 48:343–346PubMed
19.
go back to reference Alexiev BA, Drachenberg CB, Burke AP (2007) Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol 2:13PubMedCrossRef Alexiev BA, Drachenberg CB, Burke AP (2007) Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers. Diagn Pathol 2:13PubMedCrossRef
20.
go back to reference Yaman A, Yaman H (2003) Ocular myasthenia gravis coincident with thyroid ophthalmopathy. Neurol India 51:100–101PubMed Yaman A, Yaman H (2003) Ocular myasthenia gravis coincident with thyroid ophthalmopathy. Neurol India 51:100–101PubMed
21.
go back to reference Thomas CE, Mayer SA, Gungor Y et al (1997) Myasthenic crisis: clinical features, mortality complications and risk factors for prolonged intubation. Neurology 48:1253–1260PubMedCrossRef Thomas CE, Mayer SA, Gungor Y et al (1997) Myasthenic crisis: clinical features, mortality complications and risk factors for prolonged intubation. Neurology 48:1253–1260PubMedCrossRef
22.
go back to reference Tao B, Mingshan Y, Jinzhi X et al (1999) Clinical features and genetic study of the familial myasthenia gravis. Chin J Neuroimmunol Neurol 6:87–91 Tao B, Mingshan Y, Jinzhi X et al (1999) Clinical features and genetic study of the familial myasthenia gravis. Chin J Neuroimmunol Neurol 6:87–91
23.
go back to reference Hai-ping W, Shu-hui W, Zhi-qia C (2005) Clinical features and genetic susceptibility of the familial myasthenia gravis. Chin J Neurol 38:510–512 Hai-ping W, Shu-hui W, Zhi-qia C (2005) Clinical features and genetic susceptibility of the familial myasthenia gravis. Chin J Neurol 38:510–512
Metadata
Title
Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years
Authors
X. Huang
W. B. Liu
L. N. Men
H. Y. Feng
Y. Li
C. M. Luo
L. Qiu
Publication date
01-06-2013
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 6/2013
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1157-z

Other articles of this Issue 6/2013

Neurological Sciences 6/2013 Go to the issue